Instead, CXCL1 played a role in promoting angiogenesis in a paracrine manner in human vascular endothelial cells (HUVECs), and blocking CXCR2 in an orthotopic murine pancreatic cancer model reduced the tumor volume and inhibited the microvessel density [64]. Here, CXCR2 is linked to pancreatic neoplasm.